Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
US9616058B2 · kind B2 · utility
7Cited by
20References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2011 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | Feb 24, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of potent selective LSD inhibitors and LSD/MAO-B inhibitors for treating or preventing viral infections. Furthermore, the present invention relates to the new use of cyclopropylamine acetamide derivatives or cyclopropylamine derivatives, as defined herein, for treating or preventing viral infection and treating or preventing reactivation of a virus after latency.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.